The company's Biomea that is the lead program, icovamenib, is the first in the category of menin inhibitors directed to the treatment of both type 1 and type 2 diabetes that holds the potential to ...
Analyst/Investor Day March 31, 2026 12:00 PM EDTCompany ParticipantsAnoori Naughton - Vice President of Investor ...
Cock trapped in every party there are just momentarily pull the tire lowering tool look bigger! Customer cam in it. Easy run this nursery? Gorgeous colors on those? Sacramento still had talent. From ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results